These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2699998)

  • 21. Emerging roles for eicosanoids in renal diseases.
    Câmara NO; Martins JO; Landgraf RG; Jancar S
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):21-7. PubMed ID: 19077685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipids and progressive kidney disease.
    Moorhead JF
    Kidney Int Suppl; 1991 Apr; 31():S35-40. PubMed ID: 2046269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy.
    Adams LG; Polzin DJ; Osborne CA; O'Brien TD; Hostetter TH
    Lab Invest; 1994 Mar; 70(3):347-57. PubMed ID: 8145529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin: a mediator of renal disease progression.
    Bruzzi I; Remuzzi G; Benigni A
    J Nephrol; 1997; 10(4):179-83. PubMed ID: 9377723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different dietary fats influence serum and tissue lipids and anti-cardiolipin antibody levels in autoimmune-prone NZB/W F1 mice.
    Chang SC; Chiang BL; Wu WM; Lin BF
    Br J Nutr; 1999 Apr; 81(4):331-40. PubMed ID: 10999021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
    Larivière R; Moreau C; Rodrigue ME; Lebel M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eicosanoids in experimental and human renal disease.
    Stork JE; Rahman MA; Dunn MJ
    Am J Med; 1986 Jan; 80(1A):34-45. PubMed ID: 3080878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The modification of the arachidonic acid cascade by n-3 fatty acids.
    Weber PC
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():232-40. PubMed ID: 2144698
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of dietary prostaglandin precursors on the progression of renal disease in animals.
    Barcelli UO
    Kidney Int Suppl; 1991 Apr; 31():S57-64. PubMed ID: 2046272
    [No Abstract]   [Full Text] [Related]  

  • 34. Diet and kidney disease: the role of dietary fatty acids.
    Schreiner GF; Klahr S
    Proc Soc Exp Biol Med; 1991 May; 197(1):1-11. PubMed ID: 2020667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of eicosanoids in renal diseases - potential therapeutic possibilities.
    Fijałkowski M; Stępniewska J; Domański M; Ciechanowski K; Golembiewska E
    Acta Biochim Pol; 2018 Nov; 65(4):479-486. PubMed ID: 30451244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary fatty acids are also drugs.
    Dannenberg AJ; Reidenberg MM
    Clin Pharmacol Ther; 1994 Jan; 55(1):5-9. PubMed ID: 8299316
    [No Abstract]   [Full Text] [Related]  

  • 37. Eicosanoids and hypertension.
    Brater DC
    West J Med; 1990 Aug; 153(2):194-5. PubMed ID: 2145699
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of free radicals in the progression of renal disease.
    Stratta P; Canavese C; Dogliani M; Mazzucco G; Monga G; Vercellone A
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):33-7. PubMed ID: 2024670
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of fatty acids and dietary lipids on cells of the immune system.
    Calder PC
    Proc Nutr Soc; 1996 Mar; 55(1B):127-50. PubMed ID: 8832786
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of eicosanoids on the water and sodium balance of the neonate.
    Reyes JL; Melendez E
    Pediatr Nephrol; 1990 Nov; 4(6):630-4. PubMed ID: 2088466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.